Somalytics commercializes miniature sensors for eye tracking, human-machine interface, wearables, and industrial safety.
Somalytics has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in August 2022.
Somalytics's investors include IP Group, WRF Capital.
Somalytics is headquartered in Seattle, United States.
Somalytics commercializes miniature sensors for eye tracking, human-machine interface, wearables, and industrial safety.
Somalytics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Somalytics — Funding & Investors." VCBacked, August 30, 2022, https://www.vcbacked.co/company/somalytics. Accessed August 14, 2026.
VCBacked. (2022). Somalytics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/somalytics
{{cite web |title=Somalytics — Funding & Investors |url=https://www.vcbacked.co/company/somalytics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated